# Harbour BioMed's Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company

- Source: PR Newswire M&A
- Published: 2026-11-18T00:02:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/harbour-biomeds-partner-spruce-biosciences-separates-crhx-101-program-into-adrenyx-biosciences-advancing-development-of-harbour-biomed-originated-antibody-through-a-standalone-company-302942976.html
- Canonical: https://groundlevelnews.com/story/harbour-biomed-s-partner-spruce-biosciences-separates-crhx-101-program-834373/

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 17, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
